Dominik Dytfeld

Dominik Dytfeld

Poznan University of Medical Sciences - Poznan / Poland
Medical and Health Sciences / Hematology
AD Scientific Index ID: 1792253
Karol Marcinkowski University of Medical Sciences in Poznan
person_outline Dominik Dytfeld's MOST POPULAR ARTICLES
1-) Elotuzumab plus pomalidomide and dexamethasone for multiple myelomaMA Dimopoulos, D Dytfeld, S Grosicki, P Moreau, N Takezako, M Hori, ...New England Journal of Medicine 379 (19), 1811-1822, 20185172018
2-) A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myelomaAJ Jakubowiak, D Dytfeld, KA Griffith, D Lebovic, DH Vesole, S Jagannath, ...Blood, The Journal of the American Society of Hematology 120 (9), 1801-1809, 20125092012
3-) International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairmentMA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ...Journal of Clinical Oncology 34 (13), 1544-1557, 20163412016
4-) International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disordersJ Hillengass, S Usmani, SV Rajkumar, BGM Durie, MV Mateos, S Lonial, ...The lancet oncology 20 (6), e302-e312, 20194432019
5-) Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG studySK Kumar, MA Dimopoulos, E Kastritis, E Terpos, H Nahi, H Goldschmidt, ...Leukemia 31 (11), 2443-2448, 20173422017